
==== Front
J Exp Orthop
J Exp Orthop
10.1002/(ISSN)2197-1153
JEO2
Journal of Experimental Orthopaedics
2197-1153
John Wiley and Sons Inc. Hoboken

10.1002/jeo2.70002
JEO270002
Review Paper
Review Paper
Platelet‐rich plasma intra‐articular knee injections from open preparation techniques do not pose a higher risk of joint infection: A systematic review of 91 randomized controlled trials and 5914 injections
Alazzeh Mohammad Sami http://orcid.org/0000-0003-4192-7470
1
Naseh Hamza Adnan Mohammad 1
Vasiliadis Angelo http://orcid.org/0000-0002-6155-8898
2
Laupheimer Markus 3 4
Kalifis Georgios http://orcid.org/0000-0001-6528-1438
5
Al‐Dolaymi Ayyoub http://orcid.org/0000-0003-3537-6609
1 theodorakysmarin@yahoo.com

Macchiarola Luca http://orcid.org/0000-0002-2351-8836
6
Marín Fermín Theodorakys https://orcid.org/0000-0002-1698-9517
5 7
1 Aspetar Orthopaedic and Sports Medicine Hospital Doha Qatar
2 Department of Orthopaedic Surgery, Sports Trauma Unit St. Luke's Hospital Thessaloniki Greece
3 Swisssportscare Zurich Switzerland
4 The Centre for Sports & Exercise Medicine Queen Mary University of London London UK
5 Thessaloniki Minimally Invasive Surgery (TheMIS) Orthopaedic Center St. Luke's Hospital Thessaloniki Greece
6 Ospedale Casa Sollievo della Sofferenza San Giovanni Rotondo Foggia Italy
7 Centro Médico Profesional Las Mercedes Caracas Venezuela
* Correspondence Ayyoub Al‐Dolaymi, Aspetar Orthopaedic and Sports Medicine Hospital, Sports City Street, Inside Aspire Zone, Al Buwairda St, 29222 Doha, Qatar.
Email: theodorakysmarin@yahoo.com

23 9 2024
7 2024
11 3 10.1002/jeo2.v11.3 e7000201 4 2024
02 2 2024
08 5 2024
© 2024 The Author(s). Journal of Experimental Orthopaedics published by John Wiley & Sons Ltd on behalf of European Society of Sports Traumatology, Knee Surgery and Arthroscopy.
https://creativecommons.org/licenses/by/4.0/ This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Abstract

Purpose

To compare the infection rate of intraarticular platelet‐rich plasma (PRP) knee injections between open and closed techniques in randomized controlled trials (RCTs) published in the last decade.

Methods

Following the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines, PubMed, Scopus and Virtual Health Library were accessed in October 2022 using the terms ‘platelet‐rich plasma’, ‘PRP’, ‘knee’ and ‘tibiofemoral’ alone and in combination with Boolean operators AND/OR. RCTs published during the last 10 years evaluating PRP intra‐articular knee injections were considered eligible. Studies were excluded if the kit/preparation technique was not described. Data were presented using individual studies' absolute values, totals, and pooled percentages. Publication bias was assessed using the ROBIS tool.

Results

Ninety‐one studies met the predetermined eligibility criteria. Forty‐one implemented a closed technique, while 50 were open. All studies implementing a closed technique disclosed their commercial kits. Only 16 studies (17.58%) failed to report joint infections. Among the studies reporting joint infections as outcomes, 30 implemented a closed technique with 1195 patients, 1921 intra‐articular knee injections and 95.44% of patient follow‐up. On the other hand, 45 of them implemented an open technique with 2290 patients, 3993 intra‐articular knee injections and 97.07% of patient follow‐up. No patient had a joint infection among the included studies. Thirty‐three studies prepared their PRP in controlled environments (36.26%). Most studies did not report where the preparation occurred (48.35%). Only twelve studies disclosed using laminar flow during preparation (13.19%). The infection rate for both techniques was 0 per 1000 knee injections.

Conclusion

Open PRP preparation techniques do not pose a higher risk of joint infection and can lower manufacturing costs when appropriate facilities are available. However, PRP preparation setting and laminar flow implementation data are deficient, and minimal requirements for good manufacturing practices demand further studies while adhering to local and regional regulations.

Level of Evidence

Level I, systematic review of RCTs.

Graphical summary of findings of a systematic review on the infection rate of intraarticular platelet‐rich plasma knee injections between open and closed techniques in randomized controlled trials published in the last decade.

closed technique
good manufacturing practices
joint infection
laminar flow
open technique
orthobiologics
platelet‐rich plasma
Qatar National Library source-schema-version-number2.0
cover-dateJuly 2024
details-of-publishers-convertorConverter:WILEY_ML3GV2_TO_JATSPMC version:6.4.8 mode:remove_FC converted:24.09.2024
Alazzeh, M.S. , Naseh, H.A.M. , Vasiliadis, A. , Laupheimer, M. , Kalifis, G. , Al‐Dolaymi, A. et al. (2024) Platelet‐rich plasma intra‐articular knee injections from open preparation techniques do not pose a higher risk of joint infection: a systematic review of 91 randomized controlled trials and 5914 injections. Journal of Experimental Orthopaedics 11 , e70002. 10.1002/jeo2.70002
==== Body
pmcAbbreviations

PRP platelet‐rich plasma

RCT randomized controlled trial

INTRODUCTION

Platelet‐rich plasma (PRP) is a portion of autologous blood with an increased platelet concentration obtained by centrifugation [72]. It is a widely implemented regenerative medicine therapy that aims to benefit healing maximally from platelet‐derived growth factors injected into the injury site [19]. Over the last two decades, its clinical implementation has thrived, including musculoskeletal pathologies such as knee osteoarthritis, patellar tendonitis and tennis elbow [37]. Patients are particularly interested in this treatment option driven by media, celebrity athletes, the desire for novel treatments and its autologous nature [3, 63].

PRP products and preparation methods are vast and explain the heterogeneous results reported in the literature [25, 64]. Preparation methods can be classified into open and closed techniques [2, 33, 39]. In open techniques, the plasma is exposed to the environment during its preparation in the working area through pipettes and collection tubes, potentially compromising its sterility. On the other hand, closed techniques allow blood sample processing and the resulting PRP without exposing it to the environment using commercial kits, yet significantly increasing its cost [7]. However, reports on joint infections from open PRP techniques are scarce. The present study aims to compare the infection rate of intraarticular PRP knee injections between open and closed techniques in randomized controlled trials (RCTs) published in the last decade.

METHODS

This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines [67].

Search strategy

Two independent reviewers identified Eligible articles through searches of PubMed, Scopus and Virtual Health Library databases up to October 31, 2022. The terms ‘platelet‐rich plasma’, ‘PRP’, ‘knee’ and ‘tibiofemoral’ were used alone and in combination with the Boolean operators AND and OR, and an RCT article‐type filter was applied.

Eligibility criteria

Clinical studies evaluating PRP knee injections, regardless of the indication, were considered eligible for this systematic review if the following predefined criteria were fulfilled: (1) the study was conducted as an RCT; (2) PRP was given as a treatment in at least one arm of the study; (3) the study was published within the last 10 years and (4) the study was in English. Reference screening was performed on the potentially eligible articles, and an article was included when it met the eligibility criteria.

Studies were excluded if (1) PRP injections were not intra‐articular; or (2) the PRP kit/preparation technique was not described, or (3) plasma‐derived preparations other than PRP were implemented or (4) were reviews, abstracts, surveys, letters or editorials.

Data extraction

Three investigators independently reviewed the included studies, and data were extracted to a predefined Excel spreadsheet with the following variables: (1) authors; (2) year of the study; (3) study; (4) PRP technique type (open vs. closed); (5) number of patients; (6) number of joint injections; (7) lost to follow‐up; (8) number of joint infections; (9) PRP preparation setting and (10) laminar flow implementation.

Outcomes of interest

Open and closed PRP preparation techniques were defined according to Alves and Grimalt's [2]. Joint infections were accounted for when explicitly reported in the study. Studies with insufficient data to define the PRP preparation technique type or no explicit statement on the absence of joint infections were identified as ‘Not reported’ and excluded from the final analysis. The joint infection rate was defined as the number of joint infections per 1000 injections.

Statistical analysis

Data were presented in tables using the individual studies' absolute values, totals, and pooled percentages derived from them. Statistical analysis was performed using SPSS V.19 and Microsoft Excel 2016 (Microsoft®, USA).

Assessment of publication bias

The publication bias of the included studies was evaluated using the ROBIS tool [111]. This tool was rigorously developed to assess the risk of bias in systematic reviews, identify concerns with the review process and judge the risk of bias through signalling questions. These questions flag aspects of review design related to the potential for bias and aim to help assessors evaluate the risk of bias in the review process, results and conclusions.

RESULTS

Search results

The initial literature search yielded 439 potentially relevant records after excluding duplicates. After screening titles and abstracts, 106 articles for full‐text evaluation were retrieved. Ninety‐one RCTs met the predetermined eligibility criteria [1, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 16, 18, 20, 21, 23, 24, 26, 27, 28, 29, 30, 31, 32, 34, 35, 36, 38, 40, 42, 43, 44, 45, 46, 47, 48, 49, 50, 52, 54, 55, 56, 58, 59, 60, 61, 66, 68, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 113, 114, 115, 116, 117, 118, 119], and no additional study was included in the systematic review after citation screening (Figure 1).

Figure 1 Flowchart of the literature search.

Synthesis of results

Forty‐one of the included studies implemented a closed PRP technique [1, 4, 5, 6, 8, 12, 14, 16, 20, 27, 28, 29, 32, 38, 42, 43, 44, 52, 54, 56, 58, 73, 74, 78, 79, 80, 81, 82, 84, 88, 96, 97, 98, 100, 103, 106, 107, 108, 113, 114, 119], while 50 were open [7, 9, 10, 11, 13, 18, 21, 23, 24, 26, 30, 31, 34, 35, 36, 40, 45, 46, 47, 48, 49, 50, 55, 59, 60, 61, 66, 68, 75, 76, 77, 83, 85, 86, 87, 89, 90, 91, 93, 94, 95, 99, 101, 102, 104, 105, 115, 116, 117, 118] (Table S1). All studies implementing a closed PRP technique disclosed their commercial kits. Only 16 studies (17.58%) failed to report joint infections among their outcomes [1, 5, 10, 14, 16, 18, 21, 24, 27, 38, 80, 82, 85, 88, 106, 114].

Among the studies reporting joint infections as outcomes, 30 implemented a closed PRP technique with 1195 patients, 1921 intra‐articular knee injections and 95.44% of patient follow‐up [4, 6, 8, 12, 20, 28, 29, 32, 42, 43, 44, 52, 54, 56, 58, 73, 74, 78, 79, 81, 84, 96, 97, 98, 100, 103, 107, 108, 113, 119]. On the other hand, 45 of them implemented an open PRP technique with 2290 patients, 3993 intra‐articular knee injections and 97.07% of patient follow‐up [7, 9, 11, 13, 23, 26, 30, 31, 34, 35, 36, 40, 45, 46, 47, 48, 49, 50, 55, 59, 60, 61, 66, 68, 75, 76, 77, 83, 86, 87, 89, 90, 91, 93, 94, 95, 99, 101, 102, 104, 105, 115, 116, 117, 118]. No patient had a joint infection among the included studies.

Thirty‐three studies prepared their PRP in controlled environments (36.26%). Twelve studies reported preparing the PRP in laboratories [1, 6, 11, 26, 30, 46, 78, 80, 81, 82, 105, 115], nine inside the operating room [21, 27, 44, 49, 56, 60, 66, 102, 106], eight in transfusional medicine services [23, 24, 34, 59, 68, 75, 118] and four in clean rooms [48, 61, 94, 99]. Most studies did not report where the PRP preparation occurred (48.35%). Only 12 studies disclosed using laminar flow during PRP preparation (13.19%) [9, 26, 36, 48, 61, 68, 75, 93, 94, 99, 105, 117]. The infection rate for both techniques was 0 per 1000 knee injections.

Risk of publication bias results

The overall risk of bias was found to be low in all domains (Figure 2). However, missing information on PRP preparation setting among the studies may limit the extent of the study's conclusions.

Figure 2 Assessment of publication bias with ROBIS tool.

DISCUSSION

The main finding of the present systematic review is that open PRP preparation techniques do not pose a higher risk of joint infection. In fact, among 45 RCTs, 3993 intra‐articular knee injections and more than 95% follow‐up, no joint infection was reported. However, PRP preparation setting and laminar flow implementation data are deficient.

Current good manufacturing practices recommend that open techniques be handled in a Class A environment under laminar flow to diminish product contamination to negligible levels, restricting its implementation to specialized facilities [51, 92]. However, it may vary depending on local and regional regulations. The present study demonstrates that the joint infection rate after intra‐articular PRP knee injections prepared with open techniques is not higher than those prepared with closed ones. Nevertheless, the preparation setting and handling seem more relevant in preventing potential PRP product contamination than the technique. The deficient report on PRP preparation setting and laminar flow implementation among the included studies limits further recommendations.

The poor reporting quality among orthobiologics studies has been well‐documented [15, 22, 64, 71]. This study contributes to the existing literature and calls attention to journals and reviewers for the mandatory adherence to the available reporting guidelines in the submission and reviewing process [65]. Even more, current reporting guidelines fail to consider preparation settings among the relevant items that would provide scientific background in determining the minimum requirements to offer this therapy [53, 69, 70].

From an economic perspective, the cost reduction from using open PRP preparation techniques seems significant in centres with appropriate facilities [33, 68]. Available PRP commercial kits can range from US$300 to US$1.500 [3, 62], and knee injection costs can rise to US$2500 [33]. Furthermore, it has been reported that the charge data do not correlate with the cost of the goods and services required for PRP therapy [109]. Open techniques can reduce the cost of PRP to as low as US$42, which can be especially relevant in cost‐sensitive populations [7, 33, 112].

The present systematic review conveys the limitations of the analyzed studies. Conducting RCT studies demands the highest methodological quality and patient safety protocols. Thus, the joint infection rate derived from them might be lower than standard clinical practice and should not be extrapolated to office‐based settings. Cautious interpretation of the results of this study is encouraged, and meticulous and sterile PRP preparation to minimize the risk of infection when offering PRP therapy is recommended [17]. Finally, in vitro and animal studies on PRP have shown an intrinsic antimicrobial effect and minimal contamination rates [41, 57, 110]. This antimicrobial effect includes methicillin‐sensitive and methicillin‐resistant Staphylococcus aureus and Group A Streptococcus [41, 57]. Future studies should aim to assess the minimal PRP manufacturing requirements, including the need for laminar flow.

CONCLUSION

Open PRP preparation techniques do not pose a higher risk of joint infection. Open PRP preparation techniques can lower manufacturing costs when appropriate facilities are available. PRP preparation setting and laminar flow implementation data are deficient, and minimal requirements for good manufacturing practices demand further studies while adhering to local and regional regulations.

AUTHOR CONTRIBUTIONS

Mohammad Sami Alazzeh: Methodology; validation; investigation; resources; data curation; writing—review and editing. Hamza Adnan Mohammad Naseh: Methodology; validation; investigation; resources. Angelo Vasiliadis: Investigation; data curation; writing—review and editing. Markus Laupheimer: Supervision; project administration. Georgios Kalifis: Methodology; validation; investigation. Ayyoub Al‐Dolaymi: Methodology; validation; investigation. Luca Macchiarola: Methodology; validation; investigation. Theodorakys Marín Fermín: Conceptualization; methodology; validation; formal analysis; investigation; resources; data curation; writing—original draft; visualization; supervision; project administration.

CONFLICT OF INTEREST STATEMENT

The authors declare no conflict of interest.

ETHICS STATEMENT

No ethical approval was required for the presented study. No informed consent was required for the presented study.

Supporting information

Supplementary Information

ACKNOWLEDGEMENTS

The publication of this article was funded by the Qatar National Library.

DATA AVAILABILITY STATEMENT

The data underlying this article are available here and in Supporting Information.
==== Refs
REFERENCES

1 Acosta‐Olivo, C. , Esponda‐Colmenares, F. , Vilchez‐Cavazos, F. , Lara‐Arias, J. , Mendoza‐Lemus, O. & Ramos‐Morales, T. (2014) Plasma rico en plaquetas versus paracetamol oral para el tratamiento de la osteoartrosis temprana de rodilla. Estudio preliminar [Platelet rich plasma versus oral paracetamol for the treatment of early knee osteoarthritis. Preliminary study]. Cirugia y cirujanos, 82 (2 ), 163–169.25312315
2 Alves, R. & Grimalt, R. (2018) A review of platelet‐rich plasma: history, biology, mechanism of action, and classification. Skin Appendage Disorders, 4 (1 ), 18–24. Available from: 10.1159/000477353 29457008
3 Andia, I. & Maffulli, N. (2018) A contemporary view of platelet‐rich plasma therapies: moving toward refined clinical protocols and precise indications. Regenerative Medicine, 13 (6 ), 717–728. Available from: 10.2217/rme-2018-0042 30246605
4 Angoorani, H. , Mazaherinezhad, A. , Marjomaki, O. & Younespour, S. (2015) Treatment of knee osteoarthritis with platelet‐rich plasma in comparison with transcutaneous electrical nerve stimulation plus exercise: a randomized clinical trial. Medical Journal of the Islamic Republic of Iran, 29 , 223.26478881
5 Anz, A.W. , Hubbard, R. , Rendos, N.K. , Everts, P.A. , Andrews, J.R. & Hackel, J.G. (2020) Bone marrow aspirate concentrate is equivalent to platelet‐rich plasma for the treatment of knee osteoarthritis at 1 year: a prospective, randomized trial. Orthopaedic Journal of Sports Medicine, 8 (2 ), 2325967119900958. Available from: 10.1177/2325967119900958 32118081
6 Arliani, G.G. , Durigon, T.S. , Pedroso, J.P. , Ferreira, G.F. , Oksman, D. & Oliveira, V.O. (2022) Infiltração intraarticular de plasma rico em plaquetas versus ácido hialurônico em pacientes com osteoartrose primária do joelho: Ensaio clínico randomizado com resultados preliminares. Revista Brasileira de Ortopedia, 57 (3 ), 402–408. Available from: 10.1055/s-0041-1724082 35785122
7 Bansal, H. , Leon, J. , Pont, J.L. , Wilson, D.A. , Bansal, A. , Agarwal, D. et al. (2021) Platelet‐rich plasma (PRP) in osteoarthritis (OA) knee: correct dose critical for long term clinical efficacy. Scientific Reports, 11 (1 ), 3971. Available from: 10.1038/s41598-021-83025-2 33597586
8 Baria, M. , Pedroza, A. , Kaeding, C. , Durgam, S. , Duerr, R. & Flanigan, D. et al. (2022) Platelet‐rich plasma versus microfragmented adipose tissue for knee osteoarthritis: a randomized controlled trial. Orthopaedic Journal of Sports Medicine, 10 (9 ), 23259671221120678. Available from: 10.1177/23259671221120678 36147791
9 Barman, A. , Prakash, S. , Sahoo, J. , Mukherjee, S. , Maiti, R. & Roy, S.S. (2022) Single intra‐articular injection with or without intra‐osseous injections of platelet‐rich plasma in the treatment of osteoarthritis knee: a single‐blind, randomized clinical trial. Injury, 53 (3 ), 1247–1253. Available from: 10.1016/j.injury.2022.01.012 35033356
10 Bastos, R. , Mathias, M. , Andrade, R. , Amaral, R.J.F.C. , Schott, V. , Balduino, A. et al. (2019) Intra‐articular injection of culture‐expanded mesenchymal stem cells with or without addition of platelet‐rich plasma is effective in decreasing pain and symptoms in knee osteoarthritis: a controlled, double‐blind clinical trial. Knee Surgery, Sports Traumatology, Arthroscopy, 28 (6 ), 1989–1999. Available from: 10.1007/s00167-019-05732-8
11 Bastos, R. , Mathias, M. , Andrade, R. , Bastos, R. , Balduino, A. , Schott, V. et al. (2018) Intra‐articular injections of expanded mesenchymal stem cells with and without addition of platelet‐rich plasma are safe and effective for knee osteoarthritis. Knee Surgery, Sports Traumatology, Arthroscopy, 26 (11 ), 3342–3350. Available from: 10.1007/s00167-018-4883-9
12 Bennell, K.L. , Paterson, K.L. , Metcalf, B.R. , Duong, V. , Eyles, J. , Kasza, J. et al. (2021) Effect of intra‐articular platelet‐rich plasma vs placebo injection on pain and medial tibial cartilage volume in patients with knee osteoarthritis: the RESTORE randomized clinical trial. Journal of the American Medical Association, 326 (20 ), 2021–2030. Available from: 10.1001/jama.2021.19415 34812863
13 Buendía‐López, D. , Medina‐Quirós, M. & Fernández‐Villacañas Marín, M.Á. (2018) Clinical and radiographic comparison of a single LP‐PRP injection, a single hyaluronic acid injection and daily NSAID administration with a 52‐week follow‐up: a randomized controlled trial. Journal of Orthopaedics and Traumatology, 19 (1 ), 3. Available from: 10.1186/s10195-018-0501-3 30128934
14 Cerza, F. , Carnì, S. , Carcangiu, A. , Di Vavo, I. , Schiavilla, V. , Pecora, A. et al. (2012) Comparison between hyaluronic acid and platelet‐rich plasma, intra‐articular infiltration in the treatment of gonarthrosis. The American Journal of Sports Medicine, 40 (12 ), 2822–2827. Available from: 10.1177/0363546512461902 23104611
15 Chahla, J. , Cinque, M.E. , Piuzzi, N.S. , Mannava, S. , Geeslin, A.G. , Murray, I.R. et al. (2017) A call for standardization in platelet‐rich plasma preparation protocols and composition reporting: a systematic review of the clinical orthopaedic literature. Journal of Bone and Joint Surgery, 99 (20 ), 1769–1779. Available from: 10.2106/JBJS.16.01374
16 Chen, C.P.C. , Chen, J.‐L. , Hsu, C.‐C. , Pei, Y.‐C. , Chang, W.‐H. & Lu, H.‐C. (2019) Injecting autologous platelet rich plasma solely into the knee joint is not adequate in treating geriatric patients with moderate to severe knee osteoarthritis. Experimental Gerontology, 119 , 1–6. Available from: 10.1016/j.exger.2019.01.018 30664923
17 Cole, B.J. , Gilat, R. , DiFiori, J. , Rodeo, S.A. & Bedi, A. (2021) The 2020 NBA Orthobiologics Consensus Statement. Orthopaedic Journal of Sports Medicine, 9 (5 ), 232596712110022. Available from: 10.1177/23259671211002296
18 Cole, B.J. , Karas, V. , Hussey, K. , Merkow, D.B. , Pilz, K. & Fortier, L.A. (2016) Hyaluronic acid versus platelet‐rich plasma: a prospective, double‐blind randomized controlled trial comparing clinical outcomes and effects on intra‐articular biology for the treatment of knee osteoarthritis. The American Journal of Sports Medicine, 45 (2 ), 339–346. Available from: 10.1177/0363546516665809 28146403
19 Coulange Zavarro, A. , De Girolamo, L. , Laver, L. , Sánchez, M. , Tischer, T. , Filardo, G. et al. (2022) The top 100 most cited articles on platelet‐rich plasma use in regenerative medicine‐a bibliometric analysis—from the ESSKA Orthobiologic Initiative. Bioengineering, 9 (10 ), 580. Available from: 10.3390/bioengineering9100580 36290547
20 Dallo, I. , Szwedowski, D. , Mobasheri, A. , Irlandini, E. & Gobbi, A. (2021) A prospective study comparing leukocyte‐poor platelet‐rich plasma combined with hyaluronic acid and autologous microfragmented adipose tissue in patients with early knee osteoarthritis. Stem Cells and Development, 30 (13 ), 651–659. Available from: 10.1089/scd.2021.0053 33899526
21 Danieli, M.V. , Guerreiro, J.P.F. , Queiroz, A.O. , da Rosa Pereira, H. & Cataneo, D.C. (2020) Leucocyte‐poor‐platelet‐rich plasma intra‐operative injection in chondral knee injuries improve patients outcomes. A prospective randomized trial. International Orthopaedics, 45 (2 ), 463–471. Available from: 10.1007/s00264-020-04830-4 32990794
22 DeClercq, M.G. , Fiorentino, A.M. , Lengel, H.A. , Ruzbarsky, J.J. , Robinson, S.K. , Oberlohr, V.T. et al. (2021) Systematic review of platelet‐rich plasma for rotator cuff repair: are we adhering to the minimum information for studies evaluating biologics in orthopaedics? Orthopaedic Journal of Sports Medicine, 9 (12 ), 232596712110419. Available from: 10.1177/23259671211041971
23 Di Martino, A. , Boffa, A. , Andriolo, L. , Romandini, I. , Altamura, S.A. , Cenacchi, A. et al. (2022) Leukocyte‐rich versus leukocyte‐poor platelet‐rich plasma for the treatment of knee osteoarthritis: a double‐blind randomized trial. The American Journal of Sports Medicine, 50 (3 ), 609–617. Available from: 10.1177/03635465211064303 35103547
24 Di Martino, A. , Di Matteo, B. , Papio, T. , Tentoni, F. , Selleri, F. , Cenacchi, A. et al. (2018) Platelet‐rich plasma versus hyaluronic acid injections for the treatment of knee osteoarthritis: results at 5 years of a double‐blind, randomized controlled trial. The American Journal of Sports Medicine, 47 (2 ), 347–354. Available from: 10.1177/0363546518814532 30545242
25 Dohan Ehrenfest, D.M. , Rasmusson, L. & Albrektsson, T. (2009) Classification of platelet concentrates: from pure platelet‐rich plasma (P‐PRP) to leucocyte‐ and platelet‐rich fibrin (L‐PRF). Trends in Biotechnology, 27 (3 ), 158–167. Available from: 10.1016/j.tibtech.2008.11.009 19187989
26 Dório, M. , Pereira, R.M.R. , Luz, A.G.B. , Deveza, L.A. , de Oliveira, R.M. & Fuller, R. (2021) Efficacy of platelet‐rich plasma and plasma for symptomatic treatment of knee osteoarthritis: a double‐blinded placebo‐controlled randomized clinical trial. BMC Musculoskeletal Disorders, 22 (1 ), 822. Available from: 10.1186/s12891-021-04706-7 34560869
27 Duif, C. , Vogel, T. , Topcuoglu, F. , Spyrou, G. , von Schulze Pellengahr, C. & Lahner, M. (2015) Does intraoperative application of leukocyte‐poor platelet‐rich plasma during arthroscopy for knee degeneration affect postoperative pain, function and quality of life? A 12‐month randomized controlled double‐blind trial. Archives of Orthopaedic and Trauma Surgery, 135 (7 ), 971–977. Available from: 10.1007/s00402-015-2227-5 25957981
28 Dulic, O. , Rasovic, P. , Lalic, I. , Kecojevic, V. , Gavrilovic, G. , Abazovic, D. et al. (2021) Bone marrow aspirate concentrate versus platelet rich plasma or hyaluronic acid for the treatment of knee osteoarthritis. Medicina, 57 (11 ), 1193. Available from: 10.3390/medicina57111193 34833411
29 Duymus, T.M. , Mutlu, S. , Dernek, B. , Komur, B. , Aydogmus, S. & Kesiktas, F.N. (2016) Choice of intra‐articular injection in treatment of knee osteoarthritis: platelet‐rich plasma, hyaluronic acid or ozone options. Knee Surgery, Sports Traumatology, Arthroscopy, 25 (2 ), 485–492. Available from: 10.1007/s00167-016-4110-5
30 Elawamy, A. , Kamel, E.Z. , Mahran, S.A. , Abdellatif, H. & Hassanien, M. (2021) Efficacy of genicular nerve radiofrequency ablation versus intra‐articular platelet rich plasma in chronic knee osteoarthritis: a single‐blind randomized clinical trial. Pain Physician, 24 (2 ), 127–134.33740345
31 Elik, H. , Doğu, B. , Yılmaz, F. , Begoğlu, F.A. & Kuran, B. (2020) The efficiency of platelet‐rich plasma treatment in patients with knee osteoarthritis. Journal of Back and Musculoskeletal Rehabilitation, 33 (1 ), 127–138. Available from: 10.3233/BMR-181374 31127755
32 Elksniņš‐Finogejevs, A. , Vidal, L. & Peredistijs, A. (2020) Intra‐articular platelet‐rich plasma vs corticosteroids in the treatment of moderate knee osteoarthritis: a single‐center prospective randomized controlled study with a 1‐year follow up. Journal of Orthopaedic Surgery and Research, 15 (1 ), 257. Available from: 10.1186/s13018-020-01753-z 32650801
33 Fernández‐Fuertes, J. , Arias‐Fernández, T. , Acebes‐Huerta, A. , Álvarez‐Rico, M. & Gutiérrez, L. (2022) Clinical response after treatment of knee osteoarthritis with a standardized, closed‐system, low‐cost platelet‐rich plasma product: 1‐year outcomes. Orthopaedic Journal of Sports Medicine, 10 (3 ), 232596712210764. Available from: 10.1177/23259671221076496
34 Filardo, G. , Di Matteo, B. , Di Martino, A. , Merli, M.L. , Cenacchi, A. , Fornasari, P. et al. (2015) Platelet‐rich plasma intra‐articular knee injections show no superiority versus viscosupplementation. The American Journal of Sports Medicine, 43 (7 ), 1575–1582. Available from: 10.1177/0363546515582027 25952818
35 Filardo, G. , Kon, E. , Di Martino, A. , Di Matteo, B. , Merli, M.L. , Cenacchi, A. et al. (2012) Platelet‐rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial. BMC Musculoskeletal Disorders, 13 , 229. Available from: 10.1186/1471-2474-13-229 23176112
36 Filardo, G. , Kon, E. , Pereira Ruiz, M.T. , Vaccaro, F. , Guitaldi, R. , Di Martino, A. et al. (2011) Platelet‐rich plasma intra‐articular injections for cartilage degeneration and osteoarthritis: single‐ versus double‐spinning approach. Knee Surgery, Sports Traumatology, Arthroscopy, 20 (10 ), 2082–2091. Available from: 10.1007/s00167-011-1837-x
37 Fitzpatrick, J. , Bulsara, M.K. , McCrory, P.R. , Richardson, M.D. & Zheng, M.H. (2017) Analysis of platelet‐rich plasma extraction: variations in platelet and blood components between 4 common commercial kits. Orthopaedic Journal of Sports Medicine, 5 (1 ), 232596711667527. Available from: 10.1177/2325967116675272
38 Forogh, B. , Mianehsaz, E. , Shoaee, S. , Ahadi, T. , Raissi, G.R. & Sajadi, S. (2016) Effect of single injection of platelet‐rich plasma in comparison with corticosteroid on knee osteoarthritis: a double‐blind randomized clinical trial. The Journal of Sports Medicine and Physical Fitness, 56 (7–8 ), 901–908.26173792
39 Gentile, P. , Calabrese, C. , De Angelis, B. , Dionisi, L. , Pizzicannella, J. , Kothari, A. et al. (2020) Impact of the different preparation methods to obtain autologous non‐activated platelet‐rich plasma (A‐PRP) and activated platelet‐rich plasma (AA‐PRP) in plastic surgery: wound healing and hair regrowth evaluation. International Journal of Molecular Sciences, 21 (2 ), 431. Available from: 10.3390/ijms21020431 31936605
40 Ghai, B. , Gupta, V. , Jain, A. , Goel, N. , Chouhan, D. & Batra, Y.K. (2019) Efetividade do plasma rico em plaquetas no tratamento da dor em osteoartrite de joelho: estudo comparativo randômico e duplo‐cego. Brazilian Journal of Anesthesiology, 69 (5 ), 439–447. Available from: 10.1016/j.bjan.2019.06.003 31672420
41 Gilbertie, J.M. , Schaer, T.P. , Schubert, A.G. , Jacob, M.E. , Menegatti, S. , Ashton Lavoie, R. et al. (2020) Platelet‐rich plasma lysate displays antibiofilm properties and restores antimicrobial activity against synovial fluid biofilms in vitro. Journal of Orthopaedic Research, 38 (6 ), 1365–1374. Available from: 10.1002/jor.24584 31922274
42 Gobbi, A. , Dallo, I. & D'Ambrosi, R. (2023) Autologous microfragmented adipose tissue and leukocyte‐poor platelet‐rich plasma combined with hyaluronic acid show comparable clinical outcomes for symptomatic early knee osteoarthritis over a two‐year follow‐up period: a prospective randomized clinical. European Journal of Orthopaedic Surgery & Traumatology, 33 (5 ), 1895–1904. Available from: 10.1007/s00590-022-03356-2 35997833
43 Gobbi, A. , Lad, D. & Karnatzikos, G. (2014) The effects of repeated intra‐articular PRP injections on clinical outcomes of early osteoarthritis of the knee. Knee Surgery, Sports Traumatology, Arthroscopy, 23 (8 ), 2170–2177. Available from: 10.1007/s00167-014-2987-4
44 Gong, H. , Huang, B. , Zheng, Z. , Fu, L. & Chen, L. (2022) Clinical use of platelet‐rich plasma to promote tendon‐bone healing and graft maturation in anterior cruciate ligament reconstruction—a randomized controlled study. Indian Journal of Orthopaedics, 56 (5 ), 805–811. Available from: 10.1007/s43465-021-00533-z 35103026
45 Görmeli, G. , Görmeli, C.A. , Ataoglu, B. , Çolak, C. , Aslantürk, O. & Ertem, K. (2015) Multiple PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: a randomized, double‐blind, placebo‐controlled trial. Knee Surgery, Sports Traumatology, Arthroscopy, 25 (3 ), 958–965. Available from: 10.1007/s00167-015-3705-6
46 Hart, R. , Safi, A. , Komzák, M. , Jajtner, P. , Puskeiler, M. & Hartová, P. (2013) Platelet‐rich plasma in patients with tibiofemoral cartilage degeneration. Archives of Orthopaedic and Trauma Surgery, 133 (9 ), 1295–1301. Available from: 10.1007/s00402-013-1782-x 23736793
47 Huang, Y. , Liu, X. , Xu, X. & Liu, J. (2019) Intra‐articular injections of platelet‐rich plasma, hyaluronic acid or corticosteroids for knee osteoarthritis. Der Orthopäde, 48 (3 ), 239–247. Available from: 10.1007/s00132-018-03659-5 30623236
48 Joshi Jubert, N. , Rodríguez, L. , Reverté‐Vinaixa, M.M. & Navarro, A. (2017) Platelet‐rich plasma injections for advanced knee osteoarthritis: a prospective, randomized, double‐blinded clinical trial. Orthopaedic Journal of Sports Medicine, 5 (2 ), 2325967116689386. Available from: 10.1177/2325967116689386 28255569
49 Kaminski, R. , Kulinski, K. , Kozar‐Kaminska, K. , Wielgus, M. , Langner, M. , Wasko, M.K. et al. (2018) A prospective, randomized, double‐blind, parallel‐group, placebo‐controlled study evaluating meniscal healing, clinical outcomes, and safety in patients undergoing meniscal repair of unstable, complete vertical meniscal tears (bucket handle) augmented with platelet‐rich plasma. BioMed Research International, 2018 , 9315815. Available from: 10.1155/2018/9315815 29713647
50 Kaminski, R. , Maksymowicz‐Wleklik, M. , Kulinski, K. , Kozar‐Kaminska, K. , Dabrowska‐Thing, A. & Pomianowski, S. (2019) Short‐term outcomes of percutaneous trephination with a platelet rich plasma intrameniscal injection for the repair of degenerative meniscal lesions. A prospective, randomized, double‐blind, parallel‐group, placebo‐controlled study. International Journal of Molecular Sciences, 20 (4 ), 856. Available from: 10.3390/ijms20040856 30781461
51 Kawase, T. & Okuda, K. (2018) Comprehensive quality control of the regenerative therapy using platelet concentrates: the current situation and prospects in Japan. BioMed Research International, 2018 , 6389157. Available from: 10.1155/2018/6389157 29951539
52 Kesiktas, F.N. , Dernek, B. , Sen, E.I. , Albayrak, H.N. , Aydin, T. & Yildiz, M. (2020) Comparison of the short‐term results of single‐dose intra‐articular peptide with hyaluronic acid and platelet‐rich plasma injections in knee osteoarthritis: a randomized study. Clinical Rheumatology, 39 (10 ), 3057–3064. Available from: 10.1007/s10067-020-05121-4 32358661
53 Kon, E. , Di Matteo, B. , Delgado, D. , Cole, B.J. , Dorotei, A. , Dragoo, J.L. et al. (2020) Platelet‐rich plasma for the treatment of knee osteoarthritis: an expert opinion and proposal for a novel classification and coding system. Expert Opinion on Biological Therapy, 20 (12 ), 1447–1460. Available from: 10.1080/14712598.2020.1798925 32692595
54 Lamo‐Espinosa, J.M. , Blanco, J.F. , Sánchez, M. , Moreno, V. , Granero‐Moltó, F. , Sánchez‐Guijo, F. et al. (2020) Phase II multicenter randomized controlled clinical trial on the efficacy of intra‐articular injection of autologous bone marrow mesenchymal stem cells with platelet rich plasma for the treatment of knee osteoarthritis. Journal of Translational Medicine, 18 (1 ), 356. Available from: 10.1186/s12967-020-02530-6 32948200
55 Lana, J.F.S.D. , Weglein, A. , Sampson, S.E. , Vicente, E.F. , Huber, S.C. , Souza, C.V. et al. (2016) Randomized controlled trial comparing hyaluronic acid, platelet‐rich plasma and the combination of both in the treatment of mild and moderate osteoarthritis of the knee. Journal of Stem Cells and Regenerative Medicine, 12 (2 ), 69–78. Available from: 10.46582/jsrm.1202011 28096631
56 Lee, G.W. , Son, J.‐H. , Kim, J.‐D. & Jung, G.‐H. (2012) Is platelet‐rich plasma able to enhance the results of arthroscopic microfracture in early osteoarthritis and cartilage lesion over 40 years of age? European Journal of Orthopaedic Surgery & Traumatology, 23 (5 ), 581–587. Available from: 10.1007/s00590-012-1038-4 23412171
57 Li, H. & Li, B. (2013) PRP as a new approach to prevent infection: preparation and in vitro antimicrobial properties of PRP. Journal of Visualized Experiments, (74 ), 50351. Available from: 10.3791/50351 23609458
58 Lin, K.‐Y. , Yang, C.‐C. , Hsu, C.‐J. , Yeh, M.‐L. & Renn, J.‐H. (2019) Intra‐articular injection of platelet‐rich plasma is superior to hyaluronic acid or saline solution in the treatment of mild to moderate knee osteoarthritis: a randomized, double‐blind, triple‐parallel, placebo‐controlled clinical trial. Arthroscopy: The Journal of Arthroscopic & Related Surgery, 35 (1 ), 106–117. Available from: 10.1016/j.arthro.2018.06.035 30611335
59 Lisi, C. , Perotti, C. , Scudeller, L. , Sammarchi, L. , Dametti, F. , Musella, V. et al. (2017) Treatment of knee osteoarthritis: platelet‐derived growth factors vs. hyaluronic acid. A randomized controlled trial. Clinical Rehabilitation, 32 (3 ), 330–339. Available from: 10.1177/0269215517724193 28783969
60 Louis, M.L. , Dumonceau, R.G. , Jouve, E. , Cohen, M. , Djouri, R. , Richardet, N. et al. (2021) Intra‐articular injection of autologous microfat and platelet‐rich plasma in the treatment of knee osteoarthritis: a double‐blind randomized comparative study. Arthroscopy: The Journal of Arthroscopic & Related Surgery, 37 (10 ), 3125–3137.e3. Available from: 10.1016/j.arthro.2021.03.074 33887408
61 Louis, M.L. , Magalon, J. , Jouve, E. , Bornet, C.E. , Mattei, J.C. , Chagnaud, C. et al. (2018) Growth factors levels determine efficacy of platelets rich plasma injection in knee osteoarthritis: a randomized double blind noninferiority trial compared with viscosupplementation. Arthroscopy: The Journal of Arthroscopic & Related Surgery, 34 (5 ), 1530–1540.e2. Available from: 10.1016/j.arthro.2017.11.035 29366744
62 Machado, E.S. , Leite, R. , Dos Santos, C.C. , Artuso, G.L. , Gluszczak, F. , de Jesus, L.G. et al. (2019) Turn down—turn up: a simple and low‐cost protocol for preparing platelet‐rich plasma. Clinics, 74 , e1132. Available from: 10.6061/clinics/2019/e1132 31433042
63 Makaram, N.S. , Murray, I.R. , Rodeo, S.A. , Sherman, S.L. , Murray, A.D. , Haddad, F.S. et al. (2020) The use of biologics in professional and Olympic sport: a scoping review protocol. Bone & Joint Open, 1 (11 ), 715–719. Available from: 10.1302/2633-1462.111.BJO-2020-0159 33241221
64 Marín Fermín, T. , Papakostas, E. , Macchiarola, L. , Zampeli, F. , Kalifis, G. , De Girolamo, L. et al. (2022) Injectable orthobiologics in professional football (soccer) players: a systematic review. Journal of Cartilage & Joint Preservation, 2 (2 ), 100050. Available from: 10.1016/j.jcjp.2022.100050
65 Marín Fermín, T. , Scarlat, M.M. & Laupheimer, M.W. (2022) Would you have an injection without knowing its formula? New challenges in platelet‐rich plasma therapy. International Orthopaedics, 46 (10 ), 2179–2180. Available from: 10.1007/s00264-022-05566-z 36109372
66 Mochizuki, T. , Yano, K. , Ikari, K. , Hiroshima, R. , Kawakami, K. , Koenuma, N. et al. (2016) Platelet‐rich plasma for the reduction of blood loss after total knee arthroplasty: a clinical trial. European Journal of Orthopaedic Surgery & Traumatology, 26 (8 ), 901–905. Available from: 10.1007/s00590-016-1821-8 27448283
67 Moher, D. , Liberati, A. , Tetzlaff, J. & Altman, D.G. (2010) Preferred Reporting Items For Systematic Reviews and Meta‐analyses: the PRISMA statement. International Journal of Surgery, 8 (5 ), 336–341. Available from: 10.1016/j.ijsu.2010.02.007 20171303
68 Montañez‐Heredia, E. , Irízar, S. , Huertas, P. , Otero, E. , Del Valle, M. , Prat, I. et al. (2016) Intra‐articular injections of platelet‐rich plasma versus hyaluronic acid in the treatment of osteoarthritic knee pain: a randomized clinical trial in the context of the Spanish National Health Care System. International Journal of Molecular Sciences, 17 (7 ), 1064. Available from: 10.3390/ijms17071064 27384560
69 Murray, I.R. , Chahla, J. , Safran, M.R. , Krych, A.J. , Saris, D.B.F. , Caplan, A.I. et al. (2019) International expert consensus on a cell therapy communication tool: DOSES. Journal of Bone and Joint Surgery, 101 (10 ), 904–911. Available from: 10.2106/JBJS.18.00915
70 Murray, I.R. , Geeslin, A.G. , Goudie, E.B. , Petrigliano, F.A. & LaPrade, R.F. (2017) Minimum information for studies evaluating biologics in orthopaedics (MIBO): platelet‐rich plasma and mesenchymal stem cells. Journal of Bone and Joint Surgery, 99 (10 ), 809–819. Available from: 10.2106/JBJS.16.00793
71 Nazaroff, J. , Oyadomari, S. , Brown, N. & Wang, D. (2021) Reporting in clinical studies on platelet‐rich plasma therapy among all medical specialties: a systematic review of Level I and II studies. PLoS One, 16 (4 ), e0250007. Available from: 10.1371/journal.pone.0250007 33891618
72 Obana, K.K. , Schallmo, M.S. , Hong, I.S. , Ahmad, C.S. , Moorman, C.T. , Trofa, D.P. et al. (2022) Current trends in orthobiologics: an 11‐year review of the orthopaedic literature. The American Journal of Sports Medicine, 50 (11 ), 3121–3129. Available from: 10.1177/03635465211037343 34528456
73 Papalia, R. , Zampogna, B. , Russo, F. , Vasta, S. , Tirindelli, M.C. , Nobile, C. et al. (2016) Comparing hybrid hyaluronic acid with PRP in end career athletes with degenerative cartilage lesions of the knee. Journal of Biological Regulators and Homeostatic Agents, 30 (4 Suppl 1 ), 17–23.
74 Park, Y.‐B. , Kim, J.‐H. , Ha, C.‐W. & Lee, D.‐H. (2021) Clinical efficacy of platelet‐rich plasma injection and its association with growth factors in the treatment of mild to moderate knee osteoarthritis: a randomized double‐blind controlled clinical trial as compared with hyaluronic acid. The American Journal of Sports Medicine, 49 (2 ), 487–496. Available from: 10.1177/0363546520986867 33523756
75 Patel, S. , Dhillon, M.S. , Aggarwal, S. , Marwaha, N. & Jain, A. (2013) Treatment with platelet‐rich plasma is more effective than placebo for knee osteoarthritis. The American Journal of Sports Medicine, 41 (2 ), 356–364. Available from: 10.1177/0363546512471299 23299850
76 Paterson, K.L. , Nicholls, M. , Bennell, K.L. & Bates, D. (2016) Intra‐articular injection of photo‐activated platelet‐rich plasma in patients with knee osteoarthritis: a double‐blind, randomized controlled pilot study. BMC Musculoskeletal Disorders, 17 , 67. Available from: 10.1186/s12891-016-0920-3 26861957
77 Pishgahi, A. , Abolhasan, R. , Shakouri, S.K. , Soltani‐Zangbar, M.S. , Dareshiri, S. , Ranjbar Kiyakalayeh, S. et al. (2020) Effect of dextrose prolotherapy, platelet rich plasma and autologous conditioned serum on knee osteoarthritis: a randomized clinical trial. Iranian Journal of Allergy, Asthma and Immunology, 19 (3 ), 243–252. Available from: 10.18502/ijaai.v19i3.3452 32615658
78 Raeissadat, S.A. , Gharooee Ahangar, A. , Rayegani, S.M. , Minator Sajjadi, M. , Ebrahimpour, A. & Yavari, P. (2020) Platelet‐rich plasma‐derived growth factor vs hyaluronic acid injection in the individuals with knee osteoarthritis: a one year randomized clinical trial. Journal of Pain Research, 13 , 1699–1711. Available from: 10.2147/JPR.S210715 32753945
79 Raeissadat, S.A. , Ghazi Hosseini, P. , Bahrami, M.H. , Salman Roghani, R. , Fathi, M. , Gharooee Ahangar, A. et al. (2021) The comparison effects of intra‐articular injection of Platelet Rich Plasma (PRP), Plasma Rich in Growth Factor (PRGF), Hyaluronic Acid (HA), and ozone in knee osteoarthritis; a one year randomized clinical trial. BMC Musculoskeletal Disorders, 22 (1 ), 134. Available from: 10.1186/s12891-021-04017-x 33536010
80 Raeissadat, S.A. , Ghorbani, E. , Taheri, M.S. , Soleimani, R. , Rayegani, S.M. , Babaee, M. et al. (2020) MRI changes after platelet rich plasma injection in knee osteoarthritis (randomized clinical trial). Journal of Pain Research, 13 , 65–73. Available from: 10.2147/JPR.S204788 32021396
81 Raeissadat, S.A. , Rayegani, S.M. , Ahangar, A.G. , Abadi, P.H. , Mojgani, P. & Ahangar, O.G. (2017) Efficacy of intra‐articular injection of a newly developed plasma rich in growth factor (PRGF) versus hyaluronic acid on pain and function of patients with knee osteoarthritis: a single‐blinded randomized clinical trial. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders, 10 , 117954411773345. Available from: 10.1177/1179544117733452
82 Raeissadat, S.A. , Rayegani, S.M. , Hassanabadi, H. , Fathi, M. , Ghorbani, E. , Babaee, M. et al. (2015) Knee osteoarthritis injection choices: platelet‐rich plasma (PRP) versus hyaluronic acid (a one‐year randomized clinical trial). Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders, 8 , CMAMD.S17894. Available from: 10.4137/CMAMD.S17894
83 Rahimzadeh, P. , Imani, F. , Faiz, S.H.R. , Alebouyeh, M.R. , Azad‐Ehyaei, D. , Bahari, L. et al. (2016) Adding intra‐articular growth hormone to platelet rich plasma under ultrasound guidance in knee osteoarthritis: a comparative double‐blind clinical trial. Anesthesiology and Pain Medicine, 6 (6 ), e41719. Available from: 10.5812/aapm.41719 28975078
84 Rahimzadeh, P. , Imani, F. , Faiz, S.H.R. , Entezary, S.R. , Narimani Zamanabadi, M. & Alebouyeh, M.R. (2018) The effects of injecting intra‐articular platelet‐rich plasma or prolotherapy on pain score and function in knee osteoarthritis. Clinical Interventions in Aging, 13 , 73–79. Available from: 10.2147/CIA.S147757 29379278
85 Razaq, M.A. , Qasim, A.A. , Assim, T.M. & Ramzi, R. (2020) Combination of platelet‐rich plasma and hyaluronic acid in the treatment of moderate and severe osteoarthritis of the knee joint. Revmatologiia (Bulgaria), 28 (4 ), 31–35. Available from: 10.35465/28.4.2020.pp31-35
86 Reyes‐Sosa, R. , Lugo‐Radillo, A. , Cruz‐Santiago, L. , García‐Cruz, C.R. & Mendoza‐Cano, O. (2020) Clinical comparison of platelet‐rich plasma injection and daily celecoxib administration in the treatment of early knee osteoarthritis: a randomized clinical trial. Journal of Applied Biomedicine, 18 (2–3 ), 41–45. Available from: 10.32725/jab.2020.012 34907724
87 Riewruja, K. , Phakham, S. , Sompolpong, P. , Reantragoon, R. , Tanavalee, A. , Ngarmukos, S. et al. (2022) Cytokine profiling and intra‐articular injection of autologous platelet‐rich plasma in knee osteoarthritis. International Journal of Molecular Sciences, 23 (2 ), 890. Available from: 10.3390/ijms23020890 35055075
88 Ruane, J.J. , Ross, A. , Zigmont, V. , McClure, D. & Gascon, G. (2021) A single‐blinded randomized controlled trial of mesenchymal stem cell therapy for the treatment of osteoarthritis of the knee with active control. Journal of Stem Cells & Regenerative Medicine, 17 (1 ), 3–17. Available from: 10.46582/jsrm.1701002 34434003
89 Sánchez, M. , Delgado, D. , Sánchez, P. , Muiños‐López, E. , Paiva, B. , Granero‐Moltó, F. et al. (2016) Combination of intra‐articular and intraosseous injections of platelet rich plasma for severe knee osteoarthritis: a pilot study. BioMed Research International, 2016 , 4868613. Available from: 10.1155/2016/4868613 27462609
90 Say, F. , Gürler, D. , Yener, K. , Bülbül, M. & Malkoç, M. (2013) Platelet‐rich plasma injection is more effective than hyaluronic acid in the treatment of knee osteoarthritis. Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca, 80 (4 ), 278–283. Available from: 10.55095/achot2013/046 24119476
91 Sdeek, M. , Sabry, D. , El‐Sdeek, H. & Darweash, A. (2021) Intra‐articular injection of platelet rich plasma versus Hyaluronic acid for moderate knee osteoarthritis. A prospective, double‐blind randomized controlled trial on 189 patients with follow‐up for three years. Acta Orthopaedica Belgica, 87 (4 ), 729–734. Available from: 10.52628/87.4.18 35172440
92 Sebbagh, P. , Cannone, A. , Gremion, G. , Gremeaux, V. , Raffoul, W. , Hirt‐Burri, N. et al. (2023) Current status of PRP manufacturing requirements & European regulatory frameworks: practical tools for the appropriate implementation of prp therapies in musculoskeletal regenerative medicine. Bioengineering (Basel), 10 (3 ), 292. Available from: 10.3390/bioengineering10030292 36978683
93 Simental‐Mendía, M. , Acosta‐Olivo, C.A. , Hernández‐Rodríguez, A.N. , Santos‐Santos, O.R. , de la Garza‐Castro, S. , Peña‐Martínez, V.M. et al. (2019) Intraarticular injection of platelet‐rich plasma in knee osteoarthritis: single versus triple application approach. Acta Reumatologica Portuguesa, 44 (2 ), 138–144.31243258
94 Simental‐Mendía, M. , Vílchez‐Cavazos, J.F. , Peña‐Martínez, V.M. , Said‐Fernández, S. , Lara‐Arias, J. & Martínez‐Rodríguez, H.G. (2016) Leukocyte‐poor platelet‐rich plasma is more effective than the conventional therapy with acetaminophen for the treatment of early knee osteoarthritis. Archives of Orthopaedic and Trauma Surgery, 136 (12 ), 1723–1732. Available from: 10.1007/s00402-016-2545-2 27506585
95 Singh, N. , Trivedi, V. , Kumar, V. , Mishra, N.K. , Ahmad, S. , Ayar, S.J. et al. (2022) A comparative study of osteoarthritis knee arthroscopy versus intra‐articular platelet rich plasma injection: a randomised study. Malaysian Orthopaedic Journal, 16 (2 ), 31–40. Available from: 10.5704/MOJ.2207.004 35992984
96 Sit, R.W.S. , Wu, R.W.K. , Law, S.W. , Zhang, D.D. , Yip, B.H.K. , Ip, A.K.K. et al. (2019) Intra‐articular and extra‐articular platelet‐rich plasma injections for knee osteoarthritis: a 26‐week, single‐arm, pilot feasibility study. The Knee, 26 (5 ), 1032–1040. Available from: 10.1016/j.knee.2019.06.018 31375446
97 Smith, P.A. (2016) Intra‐articular autologous conditioned plasma injections provide safe and efficacious treatment for knee osteoarthritis: an FDA‐sanctioned, randomized, double‐blind, placebo‐controlled clinical trial. The American Journal of Sports Medicine, 44 (4 ), 884–891. Available from: 10.1177/0363546515624678 26831629
98 Solomon, R. , Hommen, J.P. & Travascio, F. (2022) Effects of platelet‐rich osteoconductive‐osteoinductive allograft compound on tunnel widening of ACL reconstruction: a randomized blind analysis study. Pathophysiology, 29 (3 ), 394–404. Available from: 10.3390/pathophysiology29030031 35893601
99 Spaková, T. , Rosocha, J. , Lacko, M. , Harvanová, D. & Gharaibeh, A. (2012) Treatment of knee joint osteoarthritis with autologous platelet‐rich plasma in comparison with hyaluronic acid. American Journal of Physical Medicine & Rehabilitation, 91 (5 ), 411–417. Available from: 10.1097/PHM.0b013e3182aab72 22513879
100 Stevens, H.P. , van Boxtel, J. , van Dijck, R. & van Dongen, J.A. (2020) Platelet rich STROMA, the combination of PRP and tSVF and its potential effect on osteoarthritis of the knee. Applied Sciences, 10 (14 ), 4691. Available from: 10.3390/app10144691
101 Su, K. , Bai, Y. , Wang, J. , Zhang, H. , Liu, H. & Ma, S. (2018) Comparison of hyaluronic acid and PRP intra‐articular injection with combined intra‐articular and intraosseous PRP injections to treat patients with knee osteoarthritis. Clinical Rheumatology, 37 (5 ), 1341–1350. Available from: 10.1007/s10067-018-3985-6 29388085
102 Subramanyam, K. , Alguvelly, R. , Mundargi, A. & Khanchandani, P. (2021) Single versus multi‐dose intra‐articular injection of platelet rich plasma in early stages of osteoarthritis of the knee: a single‐blind, randomized, superiority trial. Archives of Rheumatology, 36 (3 ), 326–334. Available from: 10.46497/ArchRheumatol.2021.8408 34870163
103 Sun, S.F. , Lin, G.C. , Hsu, C.W. , Lin, H.S. , Liou, I.H. & Wu, S.Y. (2021) Comparing efficacy of intraarticular single crosslinked Hyaluronan (HYAJOINT Plus) and platelet‐rich plasma (PRP) versus PRP alone for treating knee osteoarthritis. Scientific Reports, 11 (1 ), 140. Available from: 10.1038/s41598-020-80333-x 33420185
104 Szwedowski, D. , Mobasheri, A. , Moniuszko, A. , Zabrzyński, J. & Jeka, S. (2022) Intra‐articular injection of platelet‐rich plasma is more effective than hyaluronic acid or steroid injection in the treatment of mild to moderate knee osteoarthritis: a prospective, randomized, triple‐parallel clinical trial. Biomedicines, 10 (5 ), 991. Available from: 10.3390/biomedicines10050991 35625728
105 Taniguchi, Y. , Yoshioka, T. , Kanamori, A. , Aoto, K. , Sugaya, H. & Yamazaki, M. (2018) Intra‐articular platelet‐rich plasma (PRP) injections for treating knee pain associated with osteoarthritis of the knee in the Japanese population: a phase I and IIa clinical trial. Nagoya Journal of Medical Science, 80 (1 ), 39–51. Available from: 10.18999/nagjms.80.1.39 29581613
106 Torrero, J.I. , Aroles, F. & Ferrer, D. (2012) Treatment of knee chondropathy with platelet rich plasma. Preliminary results at 6 months of follow‐up with only one injection. Journal of Biological Regulators and Homeostatic Agents, 26 (2 Suppl 1 ), 71.
107 Tucker, J.D. , Goetz, L.L. , Duncan, M.B. , Gilman, J.B. , Elmore, L.W. , Sell, S.A. et al. (2021) Randomized, placebo‐controlled analysis of the knee synovial environment following platelet‐rich plasma treatment for knee osteoarthritis. PM&R, 13 (7 ), 707–719. Available from: 10.1002/pmrj.12561 33492733
108 Wang, Y.C. , Lee, C.L. , Chen, Y.J. , Tien, Y.C. , Lin, S.Y. , Chen, C.H. et al. (2022) Comparing the efficacy of intra‐articular single platelet‐rich plasma (PRP) versus novel crosslinked hyaluronic acid for early‐stage knee osteoarthritis: a prospective, double‐blind, randomized controlled trial. Medicina, 58 (8 ), 1028. Available from: 10.3390/medicina58081028 36013495
109 Werner, B.C. , Cancienne, J.M. , Browning, R. , Verma, N.N. & Cole, B.J. (2020) An analysis of current treatment trends in platelet‐rich plasma therapy in the medicare database. Orthopaedic Journal of Sports Medicine, 8 (2 ), 232596711990081. Available from: 10.1177/2325967119900811
110 White, S.K. , Schmidt, R.L. , Walker, B.S. & Metcalf, R.A. (2020) Bacterial contamination rate of platelet components by primary culture: a systematic review and meta‐analysis. Transfusion, 60 (5 ), 986–996. Available from: 10.1111/trf.15762 32181889
111 Whiting, P. , Savović, J. , Higgins, J.P.T. , Caldwell, D.M. , Reeves, B.C. , Shea, B. et al. (2016) ROBIS: a new tool to assess risk of bias in systematic reviews was developed. Journal of Clinical Epidemiology, 69 , 225–234. Available from: 10.1016/j.jclinepi.2015.06.005 26092286
112 World Health Organization and International Bank for Reconstruction and Development . (2017) Tracking universal health coverage: 2017 global monitoring report. World Health Organization.
113 Wu, Y.T. , Hsu, K.C. , Li, T.Y. , Chang, C.K. & Chen, L.C. (2018) Effects of platelet‐rich plasma on pain and muscle strength in patients with knee osteoarthritis. American Journal of Physical Medicine & Rehabilitation, 97 (4 ), 248–254. Available from: 10.1097/PHM.0000000000000874 29210705
114 Wu, Y.T. , Li, T.Y. , Lee, K.C. , Lam, K.H.S. , Chang, C.Y. , Chang, C.K. et al. (2022) Efficacy of a novel intra‐articular administration of platelet‐rich plasma one‐week prior to hyaluronic acid versus platelet‐rich plasma alone in knee osteoarthritis: a prospective, randomized, double‐blind, controlled trial. Journal of Clinical Medicine, 11 (11 ), 3241. Available from: 10.3390/jcm11113241 35683635
115 Xu, Z. , He, Z. , Shu, L. , Li, X. , Ma, M. & Ye, C. (2021) Intra‐articular platelet‐rich plasma combined with hyaluronic acid injection for knee osteoarthritis is superior to platelet‐rich plasma or hyaluronic acid alone in inhibiting inflammation and improving pain and function. Arthroscopy: The Journal of Arthroscopic & Related Surgery, 37 (3 ), 903–915. Available from: 10.1016/j.arthro.2020.10.013 33091549
116 Yaradilmis, Y.U. , Demirkale, I. , Safa Tagral, A. , Caner Okkaoglu, M. , Ates, A. & Altay, M. (2020) Comparison of two platelet rich plasma formulations with viscosupplementation in treatment of moderate grade gonarthrosis: a prospective randomized controlled study. Journal of Orthopaedics, 20 , 240–246. Available from: 10.1016/j.jor.2020.01.041 32071523
117 Yurtbay, A. , Say, F. , Çinka, H. & Ersoy, A. (2022) Multiple platelet‐rich plasma injections are superior to single PRP injections or saline in osteoarthritis of the knee: the 2‐year results of a randomized, double‐blind, placebo‐controlled clinical trial. Archives of Orthopaedic and Trauma Surgery, 142 (10 ), 2755–2768. Available from: 10.1007/s00402-021-04230-2 34705072
118 Zaffagnini, S. , Andriolo, L. , Boffa, A. , Poggi, A. , Cenacchi, A. , Busacca, M. et al. (2022) Microfragmented adipose tissue versus platelet‐rich plasma for the treatment of knee osteoarthritis: a prospective randomized controlled trial at 2‐year follow‐up. The American Journal of Sports Medicine, 50 (11 ), 2881–2892. Available from: 10.1177/03635465221115821 35984721
119 Zahir, H. , Dehghani, B. , Yuan, X. , Chinenov, Y. , Kim, C. , Burge, A. et al. (2021) In vitro responses to platelet‐rich‐plasma are associated with variable clinical outcomes in patients with knee osteoarthritis. Scientific Reports, 11 (1 ), 11493. Available from: 10.1038/s41598-021-90174-x 34075069
